Reasons to look at Aristocrat Leisure Limited

Gaming Solutions company Aristocrat Leisure Limited (ASX:ALL) has posted $858.1 million earnings before interest, tax and amortization for the year ended 30 September 2017. This reflects an improvement of 27.4% compared to the $673.4 million EBITA earned in the previous corresponding year to 30 September 2016. Net profit after tax was $495.1 million, up 41.3% on FY2016 NPAT.

Based on this result of $495.1 million profit, analyst forecasts the annual growth rate of 17.77% to $1.01 billion of NPAT by 2021. Earnings per shares increased from 54.9 cents to 77.5 cents in FY17. Analysts expects growth in earnings because of cost-cutting initiatives, since top-line is predicted to rise at a slower pace than earnings. With a current profit margin of 20.18%, analyst forecasts margin of 24.33% by 2021. [optin-monster-shortcode id=”wxhmli4jjedneglg1trq”]

In October 2017, Aristocrat completed the acquisition of 100% of Plarium global Limited, an online gaming site, for a consideration of US$500 million, which was followed by the acquisition agreement of Seattle-based casual gaming company Big Fish Games with Churchill Downs Inc. for a purchase price of US$990 million.

The company declared final dividend of 34.0 cents in the full year to 30 September 2018, which was 36% more than what company declared in the previous corresponding year.

Aristocrat’s stock is currently trading at $30.090 after moving up by 1.655% on 10 September 2018 (12:40 PM AEST). The stock has seen performance change of 40.89% over the past one year.

Dividend Stocks To Buy

The Income available from dividends remains attractive for many investors.

We take a look at the best yields on the market and assess what they say about a company’s prospect.

One Thing is certain, though, Australia interest rates are still low, making income difficult to come by and keeping the focus for many investors on high yielding stocks. Kalkine’s team of analysts bought you handpicked report for “Top 25 Dividend Stocks For 2018.”

ASX-relevant Special Reports are published year-round to provide a detailed analysis into an investing opportunity or a potential risk to your portfolio.

Click here to get your free report.


The advice given by Kalkine Pty Ltd and provided on this website is general information only and it does not take into account your investment objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. and associated websites are published by Kalkine Pty Ltd ABN 34 154 808 312 (Australian Financial Services License Number 425376). website), employees and/or associates of Kalkine Pty Ltd do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations.

Join Our Discussion

Start discussion with value Investors for ASX Stock Market Investment and Opinion.

6 Cannabis Stocks under Investor’s Limelight…

Cannabis companies that sell both medicinal weed and recreational pot. Marijuana stocks to look at. Marijuana mergers and acquisitions. Dispensary data analytics. Upcoming marijuana IPO’s Those phrases have become increasingly common as marijuana legalization spreads.

Global spending on legal cannabis is expected to grow 230% to $32 billion in 2020 as compared to $9.5 in 2017, according to Arcview Market Research and BDS Analytics. As of June 29, 2018 the United States Marijuana Index, despite a lot of uncertainty around regulations, has over the past 1 year gained 71.49%, as compared to about 12% gain seen by the S&P 500.

Click here for your FREE Report